Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,842 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Treglia G, Castaldi P, Villani MF, Perotti G, de Waure C, Filice A, Ambrosini V, Cremonini N, Santimaria M, Versari A, Fanti S, Giordano A, Rufini V. Treglia G, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):569-80. doi: 10.1007/s00259-011-2031-6. Epub 2012 Jan 6. Eur J Nucl Med Mol Imaging. 2012. PMID: 22223169
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.
Leccisotti L, Gambacorta MA, de Waure C, Stefanelli A, Barbaro B, Vecchio FM, Coco C, Persiani R, Crucitti A, Tortorelli AP, Giordano A, Valentini V. Leccisotti L, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):657-66. doi: 10.1007/s00259-014-2820-9. Epub 2015 Feb 17. Eur J Nucl Med Mol Imaging. 2015. PMID: 25687534
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.
Ripani D, Caldarella C, Za T, Pizzuto DA, Rossi E, De Stefano V, Giordano A. Ripani D, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128. doi: 10.1007/s00259-018-4108-y. Epub 2018 Jul 27. Eur J Nucl Med Mol Imaging. 2019. PMID: 30054697
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.
Rufini V, Collarino A, Calcagni ML, Meduri GM, Fuoco V, Pasciuto T, Testa AC, Ferrandina G, Gambacorta MA, Campitelli M, Gui B, Zannoni G, Manfredi R, Scambia G, Giordano A. Rufini V, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1228-1238. doi: 10.1007/s00259-019-04436-y. Epub 2019 Aug 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31414206
Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel.
Collarino A, Fuoco V, Garganese G, Pereira Arias-Bouda LM, Perotti G, Manca G, Vidal-Sicart S, Giammarile F, de Geus-Oei LF, Scambia G, Giordano A, Valdés-Olmos RA, Maccauro M. Collarino A, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1261-1274. doi: 10.1007/s00259-019-04650-8. Epub 2020 Jan 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 31897584 Review.
Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study.
Rufini V, Garganese G, Ieria FP, Pasciuto T, Fragomeni SM, Gui B, Florit A, Inzani F, Zannoni GF, Scambia G, Giordano A, Collarino A. Rufini V, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3303-3314. doi: 10.1007/s00259-021-05257-8. Epub 2021 Feb 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33619601 Free PMC article.
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study.
Caldarella C, Cocciolillo F, Taralli S, Lorusso M, Scolozzi V, Pizzuto DA, Calcagni ML, Rufini V, Guido D, Palluzzi F, Giacò L, Giordano A, Leccisotti L. Caldarella C, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1623-1629. doi: 10.1007/s00259-021-05629-0. Epub 2021 Dec 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 34877609 Free PMC article.
Quantitative analysis of myocardial blood flow in surgically revascularized and not revascularized myocardial segments. A pilot PET study.
Grandinetti M, Locorotondo G, Leccisotti L, Guarneri A, Bruno P, Marcolini A, Farina P, Gaudino MF, Lanza GA, Crea F, Giordano A, Massetti M. Grandinetti M, et al. Among authors: giordano a. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1632-1638. doi: 10.1007/s00259-023-06563-z. Epub 2023 Dec 18. Eur J Nucl Med Mol Imaging. 2024. PMID: 38105304
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials.
Ciccarese C, Bauckneht M, Zagaria L, Fornarini G, Beccia V, Lanfranchi F, Perotti G, Pinterpe G, Migliaccio F, Tortora G, Leccisotti L, Sambuceti G, Giordano A, Caffo O, Iacovelli R. Ciccarese C, et al. Among authors: giordano a. Target Oncol. 2024 Nov 29. doi: 10.1007/s11523-024-01117-1. Online ahead of print. Target Oncol. 2024. PMID: 39613950
2,842 results